Horizon Pharma HZNP today announced it has filed a patent infringement
lawsuit in the United States District Court for the District of
Delaware against Par Pharmaceutical, and related to an
Abbreviated New Drug Application that Par filed with the
U.S. Food and Drug Administration to market a generic version
of DUEXIS tablets.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in